Surgical Transmitral Thrombectomy to Prevent Recurrent Stroke in Acute Myocardial Infarction.


Journal

Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551

Informations de publication

Date de publication:
08 2023
Historique:
received: 26 06 2022
revised: 19 08 2022
accepted: 24 08 2022
medline: 11 10 2023
pubmed: 13 9 2022
entrez: 12 9 2022
Statut: ppublish

Résumé

Left ventricular (LV)-thrombi occur in up to 14 % of patients with acute myocardial infarction (AMI) in the era of primary percutaneous coronary intervention. For these patients, anticoagulant therapy (AC) is recommended by AMI-guidelines. When, despite AC, LV-thrombi lead to embolism, surgical thrombectomy is an option, which is not mentioned or not recommended in AMI-guidelines. We report a 46-year old female patient with AMI. An 80 % stenosis of the proximal left anterior descending coronary artery was treated by a drug-eluting stent. Thrombi within the akinetic LV-apex became mobile despite AC and dual antiplatelet therapy, and a cerebellar stroke occurred. By a transmitral surgical approach with endoscopic assistance the thrombi were completely removed. Postoperative course and 12-months follow-up were uneventful. LV-thrombi should be observed carefully regarding changes in morphology. Surgical thrombectomy of LV-thrombi is a rare treatment option to prevent imminent embolism. Benefits versus risks of surgical removal of LV-thrombi need to be carefully weighted.

Identifiants

pubmed: 36096876
pii: S1553-8389(22)00765-5
doi: 10.1016/j.carrev.2022.08.036
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

S307-S312

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no conflict of interest.

Auteurs

Matthias Hasun (M)

Klinik Landstraße, Juchgasse 25, 1030 Wien, Austria.

Wilfried Wisser (W)

University Hospital, Department of Cardiac Sugery, Währinger Gürtel 18-20, 1090 Wien, Austria.

Maria Heger (M)

Klinik Landstraße, Juchgasse 25, 1030 Wien, Austria.

Lisa Sow (L)

Klinik Landstraße, Juchgasse 25, 1030 Wien, Austria.

Nina Schönbrunn (N)

Klinik Landstraße, Juchgasse 25, 1030 Wien, Austria.

Josef Finsterer (J)

Klinik Landstraße, Juchgasse 25, 1030 Wien, Austria.

Claudia Stöllberger (C)

Klinik Landstraße, Juchgasse 25, 1030 Wien, Austria. Electronic address: claudia.stoellberger@chello.at.

Franz Weidinger (F)

Klinik Landstraße, Juchgasse 25, 1030 Wien, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH